SGMT (STOCKS)
Sagimet Biosciences Inc. Series A Common Stock
$8.170000
+0.625000 (+8.28%)
Prev close: $7.545000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David A. Happel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $579.32M
- Employees
- 14
- P/E (TTM)
- -5.89
- P/B (TTM)
- 1.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
10
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.26 | $-0.25 | -0.0089 | -3.54% |
|
Mar 2026 (Q1)
|
$-0.33 | $-0.38 | +0.0518 | +13.57% |
|
Dec 2025 (Q4)
|
$-0.29 | $-0.41 | +0.1249 | +30.10% |
|
Sep 2025 (Q3)
|
$-0.40 | $-0.39 | -0.0067 | -1.70% |